Hsp70 silencing with siRNA in nanocarriers enhances cancer cell death induced by the inhibitor of Hsp90

European Journal of Pharmaceutical Sciences

Volumn 50, Issue 1, 2013, Pages 149-158

  Matokanovic, Mirela ^a,b   Barisic, Karmela ^a   Filipovic Grcic, Jelena ^a   Maysinger, Dusica ^b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Cancer; Celastrol; Chitosan; Hsp70; SIRNA nanocarriers; Tumor spheroids

Indexed keywords

CELASTROL; CHITOSAN; HEAT SHOCK PROTEIN 70; SMALL INTERFERING RNA;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; FIELD FLOW FRACTIONATION; GELATION; GENE SILENCING; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; LIGHT SCATTERING; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; TUMOR SPHEROID;

EID: 84885050263     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2013.04.001     Document Type: Article

References (59)

1. Baldrick, P., 2010. The safety of chitosan as a pharmaceutical excipient. Regul. Toxicol. Pharmacol. 56, 290-299.
2. Beere, H.M., 2005. Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J. Clin. Invest. 115, 2633-2639. (Pubitemid 41434386)
3. Beere, H.M., Wolf, B.B., Cain, K., Mosser, D.D., Mahboubi, A., Kuwana, T., Tailor, P., Morimoto, R.I., Cohen, G.M., Green, D.R., 2000. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat. Cell Biol. 2, 469-475.
4. Bhattarai, N., Gunn, J., Zhang, M., 2010. Chitosan-based hydrogels for controlled, localized drug delivery. Adv. Drug Deliv. Rev. 62, 83-99.
5. Biamonte, M.A., Van de Water, R., Arndt, J.W., Scannevin, R.H., Perret, D., Lee, W.C., 2010. Heat shock protein 90: inhibitors in clinical trials. J. Med. Chem. 53, 3-17.
6. Carlsson, J., Yuhas, J.M., 1984. Liquid-overlay culture of cellular spheroids. Recent Results Cancer Res. 95, 1-23.
7. Clemons, N.J., Buzzard, K., Steel, R., Anderson, R.L., 2005. Hsp72 inhibits Fasmediated apoptosis upstream of the mitochondria in type II cells. J. Biol. Chem. 280, 9005-9012. (Pubitemid 40409592)
8. Csaba, N., Köping-Höggård, M., Alonso, M.J., 2009. Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery. Int. J. Pharm. 382, 205-214.
9. Davis, M.E., Zuckerman, J.E., Choi, C.H.J., Seligson, D., Tolcher, A., Alabi, C.A., Yen, Y., Heidel, J.D., Ribas, A., 2010. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464, 1067-1070.
10. de Jesús Valle, M.J., Dinis-Oliveira, R.J., Carvalho, F., Bastos, M.L., Sánchez Navarro, A., 2008. Toxicological evaluation of lactose and chitosan delivered by inhalation. J. Biomater. Sci. Polym. Ed. 19, 387-397.
11. de la Fuente, M., Raviña, M., Paolicelli, P., Sanchez, A., Seijo, B., Alonso, M.J., 2010. Chitosan-based nanostructures: a delivery platform for ocular therapeutics. Adv. Drug Deliv. Rev. 62, 100-117.
12. El Andaloussi, S., Lakhal, S., Mäger, I., Wood, M.J., 2012. Exosomes for targeted siRNA delivery across biological barriers. Adv. Drug Deliv. Rev., doi: http://dx.doi.org/10.1016/j.addr.2012.08.008.
13. Fernandes, J.C., Qiu, X., Winnik, F.M., Benderdour, M., Zhang, X., Dai, K., Shi, Q., 2012. Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: optimization studies. Int. J. Nanomedicine 7, 5833-5845.
14. Friedrich, J., Seidel, C., Ebner, R., Kunz-Schughart, L.A., 2009. Spheroid-based drug screen: considerations and practical approach. Nat. Protoc. 4, 309-324.
15. Fukuda, J., Khademhosseini, A., Yeo, Y., Yang, X., Yeh, J., Eng, G., Blumling, J., Wang, C.F., Kohane, D.S., Langer, R., 2006. Micromolding of photocrosslinkable chitosan hydrogel for spheroid microarray and co-cultures. Biomaterials 27, 5259-5267. (Pubitemid 44080297)
16. Gabai, V.L., Budagova, K.R., Sherman, M.Y., 2005. Increased expression of the major heat shock protein Hsp72 in human prostate carcinoma cells is dispensable for their viability but confers resistance to a variety of anticancer agents. Oncogene 24, 3328-3338. (Pubitemid 40695114)
17. Ge, P., Ji, X., Ding, Y., Wang, X., Fu, S., Meng, F., Jin, X., Ling, F., Luo, Y., 2010. Celastrol causes apoptosis and cell cycle arrest in rat glioma cells. Neurol. Res. 32, 94-100.
18. Goloudina, A.R., Demidov, O.N., Garrido, C., 2012. Inhibition of HSP70: a challenging anti-cancer strategy. Cancer Lett. 325, 117-124.
19. Gotoh, T., Terada, K., Oyadomari, S., Mori, M., 2004. Hsp70-DnaJ chaperone pair prevents nitric oxide-and CHOP-induced apoptosis by inhibiting translocation of Bax to mitochondria. Cell Death Differ. 11, 390-402. (Pubitemid 38489417)
20. Guo, F., Rocha, K., Bali, P., Pranpat, M., Fiskus, W., Boyapalle, S., Kumaraswamy, S., Balasis, M., Greedy, B., Armitage, E.S., Lawrence, N., Bhalla, K., 2005. Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin. Cancer Res. 65, 10536-10544. (Pubitemid 41743748)
21. Han, L., Zhao, J., Zhang, X., Cao, W., Hu, X., Zou, G., Duan, X., Liang, X.J., 2012. Enhanced siRNA delivery and silencing gold-chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility. ACS Nano 6, 7340-7351.
22. Hanahan, D., Weinberg, R.A., 2000. The hallmarks of cancer. Cell 100, 57-70. (Pubitemid 30046295)
23. Hanahan, D., Weinberg, R.A., 2011. Hallmarks of cancer: the next generation. Cell 144, 646-674.
24. Hirschhaeuser, F., Menne, H., Dittfeld, C., West, J., Mueller-Klieser, W., Kunz-Schughart, L.A., 2010. Multicellular tumor spheroids: an underestimated tool is catching up again. J. Biotechnol. 148, 3-15.
25. Holzerny, P., Ajdini, B., Heusermann, W., Bruno, K., Schuleit, M., Meinel, L., Keller, M., 2012. Biophysical properties of chitosan/siRNA polyplexes: profiling the polymer/siRNA interactions and bioactivity. J. Controlled Release 157, 297-304.
26. Huang, Y., Zhou, Y., Fan, Y., Zhou, D., 2008. Celastrol inhibits the growth of human glioma xenografts in nude mice through suppressing VEGFR expression. Cancer Lett. 264, 101-106.
27. Ivascu, A., Kubbies, M., 2006. Rapid generation of single-tumor spheroids for highthroughput cell function and toxicity analysis. J. Biomol. Screen. 11, 922-932. (Pubitemid 44847146)
28. Janin, Y.L., 2010. ATPase inhibitors of heat-shock protein 90, second season. Drug Discov. Today 15, 342-353.
29. Jayakumar, R., Prabaharan, M., Sudheesh Kumar, P.T., Nair, S.V., Tamura, H., 2011. Biomaterials based on chitin and chitosan in wound dressing applications. Biotechnol. Adv. 29, 322-337.
30. Jørgensen, J.A., Hovig, E., Bøe, S.L., 2012. Potent gene silencing in vitro at physiological pH using chitosan polymers. Nucleic Acid Ther. 22, 96-102.
31. Katas, H., Alpar, H.O., 2006. Development and characterisation of chitosan nanoparticles for siRNA delivery. J. Controlled Release 115, 216-225. (Pubitemid 44559708)
32. Khaitan, D., Chandna, S., Arya, M.B., Dwarakanath, B.S., 2006. Establishment and characterization of multicellular spheroids from a human glioma cell line; implications for tumor therapy. J. Transl. Med. 4, 12.
33. Kim, I.Y., Seo, S.J., Moon, H.S., Yoo, M.K., Park, I.Y., Kim, B.C., Cho, C.S., 2008. Chitosan and its derivatives for tissue engineering applications. Biotechnol. Adv. 26, 1-21.
34. Krauland, A.H., Alonso, M.J., 2007. Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system. Int. J. Pharm. 340, 134-142. (Pubitemid 47043346)
35. Leung, R.K., Whittaker, P.A., 2005. RNA interference: from gene silencing to genespecific therapeutics. Pharmacol. Ther. 107, 222-239. (Pubitemid 40910042)
36. Lord, M.S., Cheng, B., McCarthy, S.J., Jung, M., Whitelock, J.M., 2011. The modulation of platelet adhesion and activation by chitosan through plasma and extracellular matrix proteins. Biomaterials 32, 6655-6662.
37. Lu, Z., Jin, Y., Qiu, L., Lai, Y., Pan, J., 2010. Celastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation. Cancer Lett. 290, 182-191.
38. Malmo, J., Sørgård, H., Vårum, K.M., Strand, S.P., 2012. SiRNA delivery with chitosan nanoparticles: Molecular properties favoring efficient gene silencing. J. Controlled Release 158, 261-268.
39. McCollum, A.K., Lukasiewicz, K.B., Teneyck, C.J., Lingle, W.L., Toft, D.O., Erlichman, C., 2008. Cisplatin abrogates the geldanamycin-induced heat shock response. Mol. Cancer Ther. 7, 3256-3264.
40. Mehta, G., Hsiao, A.Y., Ingram, M., Luker, G.D., Takayama, S., 2012. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. J. Controlled Release 164, 192-204.
41. Mittnacht, U., Hartmann, H., Hein, S., Oliveria, H., Dong, M., Pêgo, A.P., Kjems, J., Horward, K.A., Schlosshauer, B., 2010. Chitosan/siRNA nanoparticles biofunctionalize nerve implants and enable neurite outgrowth. Nano Lett. 10, 3933-3939.
42. Mou, H., Zheng, Y., Zhao, P., Bao, H., Fang, W., Xu, N., 2011. Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria-and Fas/FasL-mediated pathways. Toxicol. In Vitro 25, 1027-1032.
43. Onozuka, H., Tsuchihara, K., Esumi, H., 2011. Hypoglycemic/hypoxic condition in vitro mimicking the tumor microenvironment markedly reduced the efficacy of anticancer drugs. Cancer Sci. 102, 975-982.
44. Park, S., Jeong, E.J., Lee, J., Rhim, T., Lee, S.K., Lee, K.Y., 2013. Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery. Carbohydr. Polym. 92 (1), 57-62.
45. Peng, B., Xu, L., Cao, F., Wei, T., Yang, C., Uzan, G., Zhang, D., 2010. HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiolcontaining agents reversible way. Mol. Cancer 9, 79.
46. Portt, L., Norman, G., Clapp, C., Greenwood, M., Greenwood, M.T., 2011. Antiapoptosis and cell survival: a review. Biochim. Biophys. Acta 1813, 238-259.
47. Powers, M.V., Clarke, P.A., Workman, P., 2008. Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis. Cancer Cell 14, 250-262.
48. Sreedhar, A.S., Csermely, P., 2004. Heat shock proteins in the regulation of apoptosis: new strategies in tumor therapy: a comprehensive review. Pharmacol. Ther. 101, 227-257. (Pubitemid 38340861)
49. Tan, M.L., Choong, P.F., Dass, C.R., 2009. Cancer, chitosan nanoparticles and catalytic nucleic acids. J. Pharm. Pharmacol. 61, 3-12.
50. Travers, J., Sharp, S., Workman, P., 2012. HSP90 inhibition: two-pronged exploitation of cancer dependencies. Drug Discov. Today 17, 242-252.
51. van den Boorn, J.G., Schlee, M., Coch, C., Hartmann, G., 2011. SiRNA delivery with exosome nanoparticles. Nat. Biotechnol. 29, 325-326.
52. Westerheide, S.D., Bosman, J.D., Mbadugha, B.N., Kawahara, T.L., Matsumoto, G., Kim, S., Gu, W., Devlin, J.P., Silverman, R.B., Morimoto, R.I., 2004. Celastrols as inducers of the heat shock response and cytoprotection. J. Biol. Chem. 279, 56053-56060. (Pubitemid 40066613)
53. Whitesell, L., Lindquist, S.L., 2005. HSP90 and the chaperoning of cancer. Nat. Rev. Cancer 5, 761-772. (Pubitemid 41400776)
54. Xiang, T.X., Li, Y., Jiang, Z., Huang, A.L., Luo, C., Zhan, B., Wang, P.L., Tao, X.H., 2008. RNA interference-mediated silencing of the Hsp70 gene inhibits human gastric cancer cell growth and induces apoptosis in vitro and in vivo. Tumori 94, 539-550.
55. Yang, X., Wang, J., Zhou, Y., Wang, Y., Wang, S., Zhang, W., 2012. Hsp70 promotes chemoresistance by blocking Bax mitochondrial translocation in ovarian cancer cells. Cancer Lett. 321, 137-143.
56. Yeh, H.Y., Liu, B.H., Hsu, S.H., 2012. The calcium-dependent regulation of spheroid formation and cardiomyogenic differentiation for MSCs on chitosan membranes. Biomaterials 33, 8943-8954.
57. Yohannes, G., Jussila, M., Hartonen, K., Riekkola, M.L., 2011. Asymmetrical flow field-flow fractionation technique for separation and characterization of biopolymers and bioparticles. J. Chromatogr. A 1218, 4104-4116.
58. Zhang, J., Xia, W., Liu, P., Cheng, Q., Tahirou, T., Gu, W., Li, B., 2010. Chitosan modification and pharmaceutical/biomedical applications. Mar. Drugs. 8, 1962-1987.
59. Zhang, S., Zhao, B., Jiang, H., Wang, B., Ma, B., 2007. Cationic lipids and polymers mediated vectors for delivery of siRNA. J. Controlled Release 123, 1-10. (Pubitemid 47444388)